Latest Therapies For Bipolar Disorder

Looking beyond lithium. Although lithium remains a player, the newer drugs, alone or in combination, can improve treatment of bipolar disorder and its assorted features.

Log in or subscribe to view full content.
Article is also available for purchase the article in one of the available formats.
Joseph F. Goldberg, MD, Leslie Citrome, MD, MPH

Table of Contents

Postgraduate Medicine:

Volume 117 No. 2


Clinical Focus

Purchase this article in one of the formats specified below:

DOI: 10.3810/pgm.2005.02.1585
Abstract: The expanding pharmacopoeia for bipolar disorder has prompted both a rethinking of the term mood stabilizer and a succession of paradigm shifts in therapy. These changes have moved the therapeutic focus from lithium to anticonvulsant drugs and, most recently, to second-generation antipsychotics as foundational treatments of bipolar disorder. Here, Drs Goldberg and Citrome summarize the latest thinking about the relative roles of newer pharmacotherapies compared with older agents. They offer suggestions on how best to approach differential pharmacotherapy decisions for bipolar disorder, as informed by current evidence-based data.